MGIA
BSX icon

Moneta Group Investment Advisors’s Boston Scientific BSX Stock Holding History

Moneta Group Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Buy
22,180
+54
+0.2% +$4.32K 0.01% 316
2025
Q4 		$2.11M Buy
22,126
+2,531
+13% +$248K 0.02% 261
2025
Q3 		$1.91M Buy
19,595
+1,369
+8% +$142K 0.02% 268
2025
Q2 		$1.96M Sell
18,226
-2,044
-10% -$207K 0.02% 225
2025
Q1 		$2.04M Sell
20,270
-400
-2% -$40.3K 0.03% 208
2024
Q4 		$1.85M Buy
20,670
+3,107
+18% +$274K 0.03% 218
2024
Q3 		$1.47M Sell
17,563
-212
-1% -$16.7K 0.02% 237
2024
Q2 		$1.37M Buy
17,775
+232
+1% +$17K 0.02% 229
2024
Q1 		$1.2M Buy
17,543
+770
+5% +$49.5K 0.02% 241
2023
Q4 		$970K Buy
16,773
+139
+0.8% +$7.42K 0.02% 245
2023
Q3 		$878K Sell
16,634
-1,511
-8% -$79.2K 0.02% 233
2023
Q2 		$981K Sell
18,145
-454
-2% -$23.7K 0.02% 226
2023
Q1 		$931K Buy
18,599
+468
+3% +$22.1K 0.02% 224
2022
Q4 		$839K Buy
18,131
+1,529
+9% +$66.2K 0.02% 220
2022
Q3 		$643K Sell
16,602
-1,885
-10% -$75.6K 0.02% 240
2022
Q2 		$689K Buy
+18,487
New +$753K 0.02% 253
2021
Q3 		– Sell
-9,238
Closed -$395K – 455
2021
Q2 		$395K Sell
9,238
-620
-6% -$26.1K 0.02% 317
2021
Q1 		$381K Buy
9,858
+484
+5% +$18.3K 0.02% 293
2020
Q4 		$337K Sell
9,374
-911
-9% -$32.8K 0.02% 239
2020
Q3 		$393K Sell
10,285
-3,244
-24% -$125K 0.03% 192
2020
Q2 		$475K Buy
13,529
+1,056
+8% +$38K 0.05% 166
2020
Q1 		$407K Buy
12,473
+3,274
+36% +$128K 0.04% 171
2019
Q4 		$416K Sell
9,199
-81,438
-90% -$3.41M 0.03% 180
2019
Q3 		$3.69M Buy
90,637
+153
+0.2% +$6.48K 0.34% 55
2019
Q2 		$3.89M Buy
90,484
+307
+0.3% +$11.8K 0.38% 46
2019
Q1 		$3.46M Sell
90,177
-570
-0.6% -$21.8K 0.36% 52
2018
Q4 		$3.21M Sell
90,747
-568
-0.6% -$20.6K 0.38% 49
2018
Q3 		$3.52M Sell
91,315
-4,531
-5% -$158K 0.36% 54
2018
Q2 		$3.13M Buy
95,846
+3,321
+4% +$100K 0.35% 46
2018
Q1 		$2.53M Buy
92,525
+1,925
+2% +$52.3K 0.34% 48
2017
Q4 		$2.25M Buy
90,600
+80,160
+768% +$2.21M 0.34% 41
2017
Q3 		$305K Sell
10,440
-63,220
-86% -$1.75M 0.05% 158
2017
Q2 		$2.04M Buy
73,660
+64,590
+712% +$1.71M 0.33% 55
2017
Q1 		$226K Buy
+9,070
New +$221K 0.04% 144
2016
Q3 		– Sell
-47,080
Closed -$1.1M – 140
2016
Q2 		$1.1M Buy
47,080
+9,975
+27% +$216K 0.24% 62
2016
Q1 		$698K Buy
+37,105
New +$652K 0.16% 86
2015
Q4 		– Sell
-668
Closed -$11K – 175
2015
Q3 		$11K Buy
+668
New +$11.4K ﹤0.01% 406

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Moneta Group Investment Advisors's BSX Position: Q1 2026 in Review

Moneta Group Investment Advisors increased its Boston Scientific (BSX) stake by 0.24% in Q1 2026, buying an estimated $4.32K and bringing the position to 22,180 shares worth $1.39M. The position accounts for 0.01% of the portfolio, ranked #316.

Moneta Group Investment Advisors first reported a position in BSX in Q3 2015 and has held it in 37 quarters since. The position peaked at $3.89M in Q2 2019. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Moneta Group Investment Advisors held 22,180 shares of Boston Scientific worth $1.39M as of Q1 2026.
  • Moneta Group Investment Advisors bought 54 Boston Scientific shares in Q1 2026, an estimated $4.32K.
  • Boston Scientific made up 0.01% of Moneta Group Investment Advisors's portfolio in Q1 2026, its #316 holding.
  • Moneta Group Investment Advisors first reported a position in Boston Scientific in Q3 2015 and has held it in 37 quarters since.
  • Moneta Group Investment Advisors's Boston Scientific position peaked at $3.89M in Q2 2019.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Moneta Group Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.